A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers

NCT01818024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

DRUG: Single IV dose of GSK2862277
DRUG: Matching placebo single dose IV infusion
DRUG: Single IH dose of GSK2862277
DRUG: Matching placebo single dose IH
DRUG: Repeat IV dose of GSK2862277
DRUG: Matching placebo repeat dose IV infusion
DRUG: Repeat IH dose selected of GSK2862277 from Part 2
DRUG: Matching placebo repeat dose IH

Sponsor

GlaxoSmithKline